Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery
NCT05315479
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class
Stopped
Anjeso (N1539) NDA Withdrawn
Conditions
Post Operative Pain
Interventions
DRUG:
N1539
Sponsor
Baudax Bio